Pharma BD Deal Intelligence
Abbott Laboratories / Knoll Pharmaceutical Company (BASF Pharma)
2001 · Acquisition/Merger · $6.9B · Complete
Announcement Sentiment
63
Positive
Abbott acquired BASF's pharmaceutical unit Knoll for ~$6.9B cash; brought in D2E7/adalimumab (later Humira) plus Synthroid, Mavik. Closed 2001-03.
Key facts
- Announced Mar 26, 2001
- Deal value $6.9B
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals